d******e
发帖数: 1424 | 1 When: March 19, 2011 (Saturday) 8:30am – 12:30 pm
Where: Institute of Americas, UCSD
Organizer: SABPA
Registration: https://www.123signup.com/register?id=vcycz
$20 for online registration, $10 for students and post-docs
$40 for on-site registration, online registration
ends March 16, 2009
Companion diagnostics, which looks for genetic, protein, or gene expression
markers to predict whether a drug works in someone or causes adverse effect,
has emerged into an exciting new trend over the last few years. With the
cost and hurdle to get a new drug approved getting higher and higher, more
and more pharma companies begin to explore using companion test to develop
safer and more effective drugs. The value of companion diagnostic tests has
already been proven by a number of marketed products, such as Hercep-Test
for Herceptin and K-RAS mutation test for Erbutux and Vectibix. Despite the
proven successes and wider awareness of companion diagnostic, pharma
companies still move slowly in adopting the new paradigm to co-develop new
drugs along with the companion tests. The regulatory hurdles, viable
business strategies, physician acceptances, insurance coverage, and many
other barriers remain unsettled for this young filed. At the SABPA Sci&Tech
forum IX, we invite a number of opinion leaders representing pharma
companies, diagnostic companies and other interest groups to share with
their insights on this rapidly growing field.
Speakers
Kenneth J. Bloom, M.D., F.C.A.P.
Chief Medical Officer, Clarient, Inc.
François Ferré, Ph.D
President and CEO of AltheaDx
Laura K. Shawver , PhD
Executive in Residence at 5AM Ventures
Founder and CEO of The Clearity Foundation
James Christensen, Ph.D.
Director, Oncology Translational Research, Pfizer
Lyle Arnold, Ph.D.
President and Founder at Aegea Biotechnologies
David Nelson, Ph.D.
President and CEO of Epic Sciences
Erik Holmlin, Ph.D.
EIR of Domain Associates
Jian-Bing Fan, Ph.D.
Senior Director, Scientific Research, Illumina | c***m
发帖数: 816 | 2 顶一下，不错
When: March 19, 2011 (Saturday) 8:30am – 12:30 pm
Where: Institute of Americas, UCSD
Organizer: SABPA
Registration: https://www.123signup.com/register?id=vcycz
$20 for online registration, $10 for students and post-docs
$40 for on-site registration, online registration
ends March 16, 2009
Companion diagnostics, which looks for genetic, protein, or gene expression
markers to predict whether a drug works in someone or causes adverse effect,
has emerged into an exciting new trend over the last few years. With the
cost and hurdle to get a new drug approved getting higher and higher, more
and more pharma companies begin to explore using companion test to develop
safer and more effective drugs. The value of companion diagnostic tests has
already been proven by a number of marketed products, such as Hercep-Test
for Herceptin and K-RAS mutation test for Erbutux and Vectibix. Despite the
proven successes and wider awareness of companion diagnostic, pharma
companies still move slowly in adopting the new paradigm to co-develop new
drugs along with the companion tests. The regulatory hurdles, viable
business strategies, physician acceptances, insurance coverage, and many
other barriers remain unsettled for this young filed. At the SABPA Sci&Tech
forum IX, we invite a number of opinion leaders representing pharma
companies, diagnostic companies and other interest groups to share with
their insights on this rapidly growing field.
Speakers
Kenneth J. Bloom, M.D., F.C.A.P.
Chief Medical Officer, Clarient, Inc.
François Ferré, Ph.D
President and CEO of AltheaDx
Laura K. Shawver , PhD
Executive in Residence at 5AM Ventures
Founder and CEO of The Clearity Foundation
James Christensen, Ph.D.
Director, Oncology Translational Research, Pfizer
Lyle Arnold, Ph.D.
President and Founder at Aegea Biotechnologies
David Nelson, Ph.D.
President and CEO of Epic Sciences
Erik Holmlin, Ph.D.
EIR of Domain Associates
Jian-Bing Fan, Ph.D.
Senior Director, Scientific Research, Illumina
【在 d******e 的大作中提到】
: When: March 19, 2011 (Saturday) 8:30am – 12:30 pm
: Where: Institute of Americas, UCSD
: Organizer: SABPA
: Registration: https://www.123signup.com/register?id=vcycz
: $20 for online registration, $10 for students and post-docs
:
: $40 for on-site registration, online registration
: ends March 16, 2009
: Companion diagnostics, which looks for genetic, protein, or gene expression
: markers to predict whether a drug works in someone or causes adverse effect,
| d******e
发帖数: 1424 | | s*******e
发帖数: 806 | | d******e
发帖数: 1424 | 5 Corrected. Thanks for catching it.
【在 s*******e 的大作中提到】
: March 16, 2009???
| d******e
发帖数: 1424 | | d******e
发帖数: 1424 | 7 A-Bio/Luye Recruiting Event
When: March 19, 2011 (Saturday) 1-5PM
Where: Institute of Americas, UCSD
Organizer: SABPA
Event Website: http://www.sabpa.org
Based in Singapore, A-Bio Pharma Pte Ltd (www.a-bio.com) is one of Asia's
pioneering biologics contract manufacturers since 2003. In 2010, Luye Pharma
Group (www.luye.cn), a Singapore-listed, China-based pharmaceutical company
became the major shareholder of A-Bio, enabling it to serve as the R&D
center for their biologics pipeline, aiming at China’s rapidly growing
biopharmaceutical market and unmet medical needs.
Entering a phase of fast expansion in biological therapeutics such as
monoclonal antibodies, A-Bio and Luye will be hosting a recruiting event for
experienced bio-pharmaceutical professional after the Sci&Tech Forum:
1PM-2PM Lunch and networking (Sponsored by A-Bio and Luye)
2PM-3PM A-Bio/Luye recruiting presentations (a Q&A session included)
3PM-5PM Reception and one-on-one interviews with A-Bio and Luye
For detailed description of open positions at A-Bio/Luye and to schedule one
-on-one interviews, please go to http://www.sabpa.org/web/careers/ABIO_Feb2010_JobDescription.htm
A-Bio/Luye team members who are hosting this event:
Dr. Steven LEE CEO of A-Bio Pharma Pte Ltd
Dr. Dongxiao FENG Director of Biotechnology Development, Luye Pharma Group
Dr. Gang CHENG Manager of International Technology Transfer and
Collaboration, Luye Pharma Group | d******e
发帖数: 1424 | 8 On-line registration closes on Wednesday. |
|
